Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BIIB
BIIB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BIIB News
Denali Sells Rare Pediatric Disease Priority Review Voucher for $195 Million
17h ago
NASDAQ.COM
Biotech Sector Sees FDA Approvals and Layoffs
21h ago
NASDAQ.COM
U.S. Stock Futures Rise as Investors Eye Four Key Stocks
1d ago
seekingalpha
Biogen Acquires RayThera to Expand Immunology Pipeline
2d ago
seekingalpha
Biogen Acquires RayThera for Up to $1 Billion
2d ago
NASDAQ.COM
Biogen Acquires RayThera to Enhance Immunology Pipeline
2d ago
stocktwits
Biogen Acquires RayThera for Up to $1 Billion
2d ago
Newsfilter
Pomerantz LLP Investigates Biogen for Securities Fraud
3d ago
Globenewswire
Biogen Under Investigation for Securities Fraud Claims
Jun 11 2026
PRnewswire
Biogen Faces Investigation Over Securities Violations
Jun 10 2026
Globenewswire
Biogen Under Investigation for Potential Securities Fraud
Jun 09 2026
Globenewswire
Latest Wall Street Ratings Overview
Jun 08 2026
CNBC
Revolution Medicines Achieves Strong Phase 3 Clinical Trial Results
Jun 05 2026
NASDAQ.COM
Revolution Medicines Stock Soars 285% Amid Clinical Progress
Jun 05 2026
Fool
Pharmaceutical Giants Accelerate Acquisitions to Offset Patent Cliffs
Jun 05 2026
stocktwits
Biogen's Salanersen Receives FDA Breakthrough Therapy Designation
Jun 04 2026
NASDAQ.COM
Show More News
